Possible role of plasma neurotensin on growth hormone regulation in neonates

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue 5, 1998, Pages 607-613

  Bozzola, Mauro ^a   Ntodou Thome, Agnes ^b   Bona, Gianni ^c   Autelli, Michele ^d   Magnani, Maria Luisa ^a   Radetti, Giorgio ^e   Schimpff, Rose Marie ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b INSERM   (France)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e Department of Pediatrics ^*  (Italy)

Author keywords

Growth hormone; Infants; Insulin like growth factor I; Neurotensin

Indexed keywords

GROWTH HORMONE; NEUROTENSIN; SOMATOMEDIN C; SOMATOSTATIN;

ADULT; AGE; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; NEWBORN; NORMAL HUMAN; PREPUBERTY;

EID: 0031759833     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1998.11.5.607     Document Type: Article

References (32)

1. Eckland DJA, Lightman SL. Neurotensin is secreted into the rat hypothalamo-hypophyseal portal system. Regul Peptides 1981; 13: 98-102.
2. Young WS III, Kuhar MJ. Neurotensin receptor localisation by light microscopic autoradiography in rat brain. Brain Res 1981; 206: 273-285.
3. Uhl GR Distribution of neurotensin and its receptor in the central nervous system Ann NY Acad Sci 1982; 400: 132-149.
4. Carraway R, Kitabgi P, Leeman SE. The aminosequence of radioimmunoassayable neurotensin from bovine intestine. Identity to neurotensin from hypothalamus. J Biol Chem 1978; 253: 7996-8001.
5. Hammer RA, Leeman SE, Carraway R, William R. Isolation of human intestinal neurotensin. J Biol Chem 1980; 255: 2476-2480.
6. Ferris CF, Hammer RA, Leeman SE. Elevation of plasma neurotensin during lipid perfusion of rat small intestine. Peptides 1981; 2: 263-266.
7. Ferris CF, George JK, Eastwood G, Potegal M, Carraway R. Plasma levels of human neurotensin: methodological and physiological considerations. Peptides 1991; 12: 215-220.
8. Schimpff R M, Bozzola M, Lhiaubet A M, Spadaro B, Tettoni K, Rostene W. Effects of growth hormone administration on neurotensin release in children with growth delay. Horm Res 1994; 42: 95-99.
9. Schimpff R M, Lhiaubet AM, Vial M, Rostene W. Blood peripheral human lymphocytes: a possible source for plasma levels of neurotensin. Prog Neuroendocr Immunol 1992; 5: 126-131.
10. Rivier C, Brown M, Vale W. Effect of neurotensin, substance P and morphine sulphate on the secretion of prolactin and growth hormone in the rat. Endocrinology 1977; 100: 751-754.
11. Maeda K, Frohman LA. Dissociation of systemic and central effects of neurotensin on the secretion of growth hormone, prolactin and thyrotropin. Endocrinology 1978; 103: 1903-1909.
12. Berry SA, Gudelsky GA. Evidence for protein C mediation of neurotensin-induced activation of tyrosine hydroxylase in tuberoinfundibular dopaminergic neurons. Endocrinology 1992; 131: 1207-1211.
13. Rostene W, Brouard A, Dana C, Masuo Y, Agid F, Vial M, Lhiaubet AM, Pelaprat D. Interaction between neurotensin and dopamine in the brain. Ann NY Acad Sci 1992; 668: 217-231.
14. Frohman L A, Maeda K, Berelowitz M, Szabo M, Thominet J. Effects of neurotensin on hypothalamic and pituitary hormone secretion. Ann NY Acad Sci 1982; 400: 172-182.
15. Schimpff RM, Gourmelen M, Scarceriaux V, Lhiaubet AM, Rostene W. Plasma neurotensin levels in humans: relation to hormone levels in diseases involving the hypothalamo-pituitary-thyroid axis. Eur J Endocrinol 1995; 133: 534-538.
16. Deutch AY, Bean AJ, Bissette G, Nemeroff CB, Robbins RJ, Roth RH. Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions. Brain Res 1987; 417: 350-354.
17. Kilts CD, Coco ML, Ely TD, Bissette G, Nemeroff CB. Differential effects of conditioned and unconditioned stress on the neurotensin content of dopamine cell body groups of the ventral mesencephalon. Ann NY Acad Sci 1992; 668: 266-276.
18. Bozzola M, Tettoni K, Locatelli F, Radetti G, Belloni C, Autelli M, Zecca M, Valentini R, Severi F, Tatò L. Postnatal variations of growth hormone bioactivity and of growth hormone-dependent factors. Arch Pediatr Adolesc Med 1996; 150: 1068-1071.
19. Comblath M, Parker ML, Reisner SH, Forbes AE, Daughaday WH. Secretion and metabolism of growth hormone in premature and full-term infants. J Clin Endocrinol 1965; 25: 209-218.
20. Wang HS, Lim J, English J, Irvine L, Chard T. The concentrations of insulin-like growth factor-I (IGF-1) and insulin-like growth factor binding protein-1 (IGFBP-1) in human umbilical cord serum at delivery: relation with fetal weight. J Endocrinol 1991; 129: 459-464.
21. Gluckman PD, Johnson-Barrett JJ, Bluter JH, Edgar BW, Gunn TR. Studies of insulin-like growth factor-I and II by specific radioligand assay in umbilical cord blood. Clin Endocrinol (Oxf) 1983; 19: 405-413.
22. de Zegher F, Styne DM, Daaboul J, Bettendorf J, Kaplan SL, Grumbach MM. Hormone ontogeny in the ovine fetus and neonatal lamb. XX. Effect of age, breeding season and twinning on the growth hormone (GH) response to GH-releasing factor: evidence for a homeostatic role of fetal GH. Endocrinology 1989; 124: 124-128.
23. Deiber M, Chatelain P, Naville D, Putet G, Salle B. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. J Clin Endocrinol Metab 1989; 68: 232-234.
24. de Zegher F, Bettendorf M, Kaplan SL, Grumbach MM. Hormone ontogeny in the ovine fetus and neonatal lamb. XXI. Effect of exogenous insulin-like growth factor-1 on plasma growth hormone, insulin and glucose concentrations. Endocrinology 1988; 123: 658-660.
25. Shibasaki T, Yamauchi N, Hotta M, Masuda A, Imaki T, Demura H,Ling N, Shizume K. In vitro release of growth hormone-releasing factor from rat hypothalamus: effect of insulin-like growth factor I. Regul Pept 1986; 15: 47-53.
26. Berolowitz M, Szabo M, Frohman IA, Firestone S, Chu L, Hintz RL. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 1984; 212: 1279-1281.
27. Cotteril AM, Camacho-Hubner C, Holly JMP, Savage MO. The effect of recombinant human insulin-like growth factor-1 treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome). Clin Endocrinol (Oxf) 1993; 39: 119-122.
28. McCann SM, Vijayan E. Control of anterior pituitary hormone secretion by neurotensin. Ann NY Acad Sci 1992; 668: 287-297.
29. Blackburn AM, Fletcher DR, Adrian TE, Bloom SR. Neurotensin infusion in man: pharmacokinetics and effect on gastrointestinal and pituitary hormones. J Clin Endocrinol Metab 1980; 51: 1257-1261.
30. Reichlin S. Somatostatin. In: Krieger DT, Brownstein M, Martin JB, eds. Brain Peptides. New York: John Wiley & Son, 1983; 711-712.
31. Vijayan E, McCann SM. Effects of substance P and neurotensin on growth hormone and thyrotropin release in vivo and in vitro. Life Sci 1979; 26: 321-327.
32. Vijayan E, Carraway R, Leeman SE, McCann SM. Control of anterior pituitary hormone secretion by neurotensin. Physiological significance of neurotensin in pituitary glycoprotein hormone release as revealed by in vivo and in vitro studies with neurotensin antiserum Neuroendocrinology 1994; 60: 157-164.